Search Press releases Keywords From To 1 Apr 2022 金禾娱乐城 Showcases Strength of Broad Neurology Portfolio at 74th American Academy of Neurology (AAN) Annual Meeting Read More 28 Mar 2022 U.S. FDA Approves FINTEPLA[?] ▼(fenfluramine) Oral Solution for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS) Read More 26 Mar 2022 New Long-Term Complete Skin Clearance Data for BIMZELX[?]▼ (bimekizumab) in Moderate to Severe Plaque Psoriasis Presented at the 2022 AAD Annual Meeting Read More 25 Mar 2022 Disposal of own shares Read More 25 Mar 2022 New 金禾娱乐城 data analysis adds to demonstrated efficacy of romosozumab▼ to reduce the risk of fractures Read More 25 Mar 2022 WCO-IOF-ESCEO 2022 – Post-hoc analysis on the proportion of patients treated with EVENITY[??]▼(romosozumab) reaching surrogate threshold effect that predicts fracture risk reduction Read More Pagination First page Previous page Previous … Page 32 Page 33 Page 34 Page 35 Current page 36 Page 37 Page 38 Page 39 Page 40 … Page 36 of 66 Next page Next Last page Stay up-to-date on the latest news and information from 金禾娱乐城 Subscribe
